SWI/SNF Mutations Confer Resistance to Ibrutinib plus Venetoclax in MCL.
Sign Up to like & getrecommendations! Published in 2019 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-rw2018-210
Abstract: Biomarker analysis of a phase II trial reveals mechanisms of resistance to BTK and BCL2 inhibition. read more here.
Keywords: snf mutations; resistance; mutations confer; swi snf ... See more keywords